Histamine and schizophrenia

被引:34
|
作者
Arrang, Jean-Michel [1 ]
机构
[1] INSERM, U573, Unite Neurobiol & Pharmacol Mol, Ctr Paul Broca, F-75014 Paris, France
来源
INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA | 2007年 / 78卷
关键词
D O I
10.1016/S0074-7742(06)78009-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
With the availability of an increased number of experimental tools, for example potent and brain-penetrating H-1-, H-2-, and H-3-receptor ligands and mutant mice lacking the histamine synthesis enzyme or the histamine receptors, the functional roles of histaminergic neurons in the brain have been considerably clarified during the recent years, particularly their major role in the control of arousal, cognition, and energy balance. Various approaches tend to establish the implication of histaminergic neurons in schizophrenia. A strong hyperactivity of histamine neurons is induced in rodent brain by administration of methamphetamine or NMDA-receptor antagonists. Histamine neuron activity is modulated by typical and atypical neuroleptics. H-3-receptor antagonists/ inverse agonists display antipsychotic-like properties in animal models of the disease. Because of the limited predictability value of most animal models and the paucity of drugs affecting histaminergic transmission that were tried so far in human, the evidence remains therefore largely indirect, but supports a role of histamine neurons in schizophrenia.
引用
收藏
页码:247 / +
页数:42
相关论文
共 50 条
  • [21] Histamine N-methyltransferase functional polymorphism: Lack of association with schizophrenia
    Yan, L
    Szumlanski, CL
    Rice, SR
    Sobell, JL
    Lachman, HM
    Weinshilboum, RM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (03): : 404 - 406
  • [22] A randomized clinical trial of histamine 2 receptor antagonism in treatment resistant schizophrenia
    Meskanen, K.
    Ekelund, H.
    Laitinen, J.
    Neuvonen, P. J.
    Haukka, J.
    Panula, P.
    Ekelund, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S461 - S461
  • [23] Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response
    Mancama, D
    Arranz, MJ
    Munro, J
    Osborne, S
    Makoff, A
    Collier, D
    Kerwin, R
    NEUROSCIENCE LETTERS, 2002, 333 (03) : 207 - 211
  • [24] Targeting the Central Histamine H2 Receptor: New Hope for Schizophrenia?
    Lin, Wenkai
    Yu, Xuemin
    Zhu, Xinyan
    NEUROSCIENCE BULLETIN, 2024, 40 (01): : 143 - 145
  • [25] Histamine H2 receptor gene variants: lack of association with schizophrenia
    C Ito
    S Morisset
    M-O Krebs
    J-P Olié
    H Lôo
    M-F Poirier
    L Lannfelt
    J-C Schwartz
    J-M Arrang
    Molecular Psychiatry, 2000, 5 : 159 - 164
  • [26] Histamine H2 receptor gene variants:: lack of association with schizophrenia
    Ito, C
    Morisset, S
    Krebs, MO
    Olié, JP
    Lôo, H
    Poirier, MF
    Lannfelt, L
    Schwartz, JC
    Arrang, JM
    MOLECULAR PSYCHIATRY, 2000, 5 (02) : 159 - 164
  • [27] Targeting the Central Histamine H2 Receptor: New Hope for Schizophrenia?
    Wenkai Lin
    Xuemin Yu
    Xinyan Zhu
    Neuroscience Bulletin, 2024, 40 : 143 - 145
  • [28] Novel polymorphisms in the histamine 1 and 2 receptor genes, schizophrenia and clozapine drug response
    Mancama, D
    Munro, J
    Arranz, MJ
    Makoff, A
    Kerwin, R
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 242 - 242
  • [29] A Randomized Clinical Trial of Histamine 2 Receptor Antagonism in Treatment-Resistant Schizophrenia
    Meskanen, Katarina
    Ekelund, Heidi
    Laitinen, Jarmo
    Neuvonen, Pertti J.
    Haukka, Jari
    Panula, Pertti
    Ekelund, Jesper
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (04) : 472 - 478
  • [30] EFFECTS OF FAMOTIDINE, A HISTAMINE-H2-RECEPTOR ANTAGONIST, ON NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
    KAMINSKI, R
    MORIARTY, T
    CULLITON, D
    PRELL, GD
    BODINE, J
    DAVIS, KL
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 318 - 319